Home › NCT05836597
Functional Dyspepsia Treatment Using Virtual Reality
Recruiting
Effectiveness and Safety of Virtual Reality for the Treatment of Functional Dyspepsia
Who can join
Ages 18 to 75 · All sexes
Full eligibility criteria
Inclusion Criteria: * Symptoms of dyspepsia thought to represent functional dyspepsia, meeting Rome IV criteria * Had an upper endoscopy and assessment for Helicobacter pylori; if a patient is found to have H. pylori, treatment with confirmed eradication (by stool antigen test or urea breath test) will be required before the patient is eligible for study inclusion. * Patients will be considered for the study if they have undergone a complete history and physical examination during a previously scheduled consultation/evaluation visit with a gastroenterologist in the Mayo Clinic Florida General GI or Motility clinic. Exclusion Criteria: * Symptoms are thought to represent an organic disorder (e.g., peptic ulcer disease, hepatitis, pancreatitis, inflammatory bowel disease, type I diabetes, a known malignancy, radiation-induced injury, an active infection, vasculitis, celiac disease), or patients have known uncontrolled GERD, esophagitis, eosinophilic esophagitis, or untreated H. pylori. * Patients with gastroparesis or cyclic vomiting syndrome. * Patients with prior surgery to the esophagus, stomach or duodenum. * Patients taking opioids. * Patients with motion sickness, vertigo, or a seizure disorder * IBS symptoms are not predominant.
About the study
The purpose of this study is to evaluate the effectiveness of using virtual reality to treat gastrointestinal symptoms related to functional dyspepsia.
What is being tested
- Virtual reality (device)
Sponsor: Mayo Clinic · Participants: 30 · Started: Apr 1, 2024
Contact the study team
Official record on ClinicalTrials.gov — NCT05836597
Locations in the U.S.
| Florida | Mayo Clinic in Florida, Jacksonville |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.